Canon Medical Research Europe has been awarded further funding of £140k to undertake a 6 month development and evaluation of a proof of concept/prototype using deep machine learning in the detection /reporting of mesotheliomal tumours.

“Working closely with our collaborators at NHS Greater Glasgow and Clyde’s Department of Respiratory Medicine, Canon Medical will use their decades of experience in medical image analysis to develop state-of-the art tumour segmentation methods for CT, specifically targeted to support RECIST reporting for MPM.”

Further information on the project can be found below:


Event registration is available via the following link: